Ingoglia Filippo, Visigalli Rossana, Rotoli Bianca Maria, Barilli Amelia, Riccardi Benedetta, Puccini Paola, Dall'Asta Valeria
Dept. of Biomedical, Biotechnological and Translational Sciences (SBiBiT), University of Parma, Via Volturno 39, 43125 Parma, Italy.
Preclinical Pharmacokinetics, Biochemistry & Metabolism Dept., Chiesi Farmaceutici, Largo F. Belloli 11/A, 43122 Parma, Italy.
Biochim Biophys Acta. 2015 Jul;1848(7):1563-72. doi: 10.1016/j.bbamem.2015.04.001. Epub 2015 Apr 13.
Organic cation transporters (OCT1-3) mediate the transport of organic cations including inhaled drugs across the cell membrane, although their role in lung epithelium hasn't been well understood yet. We address here the expression and functional activity of OCT1-3 in human airway epithelial cells A549, Calu-3 and NCl-H441. Kinetic and inhibition analyses, employing [(3)H]1-methyl-4-phenylpyridinium (MPP+) as substrate, and the compounds quinidine, prostaglandine E2 (PGE2) and corticosterone as preferential inhibitors of OCT1, OCT2, and OCT3, respectively, have been performed. A549 cells present a robust MPP+ uptake mediated by one high-affinity component (Km~50μM) which is identifiable with OCT3. Corticosterone, indeed, completely inhibits MPP+ transport, while quinidine and PGE2 are inactive and SLC22A3/OCT3 silencing with siRNA markedly lowers MPP+ uptake. Conversely, Calu-3 exhibits both a high (Km<20μM) and a low affinity (Km>0.6mM) transport components, referable to OCT3 and OCT1, respectively, as demonstrated by the inhibition analysis performed at proper substrate concentrations and confirmed by the use of specific siRNA. These transporters are active also when cells are grown under air-liquid interface (ALI) conditions. Only a very modest saturable MPP+ uptake is measurable in NCl-H441 cells and the inhibitory effect of quinidine points to OCT1 as the subtype functionally involved in this model. Finally, the characterization of MPP+ transport in human bronchial BEAS-2B cells suggests that OCT1 and OCT3 are operative. These findings could help to identify in vitro models to be employed for studies concerning the specific involvement of each transporter in drug transportation.
有机阳离子转运体(OCT1 - 3)介导包括吸入药物在内的有机阳离子跨细胞膜的转运,尽管它们在肺上皮细胞中的作用尚未完全明确。我们在此研究了OCT1 - 3在人呼吸道上皮细胞A549、Calu - 3和NCl - H441中的表达及功能活性。采用[³H]1 - 甲基 - 4 - 苯基吡啶鎓(MPP⁺)作为底物,并分别使用奎尼丁、前列腺素E2(PGE2)和皮质酮作为OCT1、OCT2和OCT3的优先抑制剂进行了动力学和抑制分析。A549细胞呈现出由一个高亲和力成分(Km约为50μM)介导的强大MPP⁺摄取,该成分可鉴定为OCT3。实际上,皮质酮完全抑制MPP⁺转运,而奎尼丁和PGE2无活性,并且用小干扰RNA(siRNA)沉默SLC22A3/OCT3可显著降低MPP⁺摄取。相反,Calu - 3表现出高亲和力(Km < 20μM)和低亲和力(Km > 0.6mM)两种转运成分,分别对应于OCT3和OCT1,这通过在适当底物浓度下进行的抑制分析得以证明,并通过使用特异性siRNA得到证实。当细胞在气液界面(ALI)条件下生长时,这些转运体也具有活性。在NCl - H441细胞中仅可测量到非常适度的可饱和MPP⁺摄取,奎尼丁的抑制作用表明OCT1是该模型中起功能作用的亚型。最后,人支气管BEAS - 2B细胞中MPP⁺转运的特征表明OCT1和OCT3具有活性。这些发现有助于确定用于研究每种转运体在药物转运中具体作用的体外模型。